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Abstract. 
 
The objective was to evaluate the indicators of pain, anxiety and depression through 
early screening in patients admitted to a palliative care oncology service. This was a 
cross-sectional with outpatients. We used the Hospital Anxiety Depression Scale; 
Visual Analog Scale of Pain and sociodemographic information from the medical 
record. 70 (32.6%) patients had some degree of pain. And moderate or excruciating 
10 (5%), pain. It was found that 80 (37.2%) patients had anxiety and 84 (39.1%) 
depression. And 48 (22.4%) and 60 (27.9%) of them were within the moderate or 
severe levels for anxiety and depression respectively. Early tracking of pain, anxiety 
and depression is recommended to favor immediate patients admitted to hospice care 
practice. 
 
Keywords: Early detection; anxiety; depression; palliative care. 
 
Resumo. 
 
O objetivo foi avaliar os indicadores de dor, ansiedade e depressão através de 
rastreamento precoce em pacientes admitidos em um serviço de cuidados paliativos 
oncológico. Este foi do tipo transversal com pacientes ambulatoriais. Utilizou-se a 
Hospital Anxiety Depression Scale; Escala Analógica Visual de Dor e informações 
sócio demográficas do prontuário. 70 (32,6%) dos pacientes apresentavam algum 
grau de dor. E 10 (5%) dor moderada ou insuportável. Detectou-se que 80 (37,2%) 
dos pacientes apresentaram ansiedade e 84 (39,1%) depressão. Sendo que 48 
(22,4%) e 60 (27,9%) deles encontravam-se dentro dos níveis moderado ou severo 
para ansiedade e depressão respectivamente. O rastreamento precoce de dor, 
ansiedade e depressão é uma prática recomendável para favorecer atendimento 
imediato a pacientes admitidos em cuidados paliativos. 
 
Palavras-chave: Detecção precoce; ansiedade; depressão; cuidados paliativos. 
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Background. 
 
The transition from the prospect of achieving a cure to treatment at a palliative care 
service is often a traumatic period characterised by confusion, uncertainty and loss of 
control among patients and family members.1-3 After patients have been told that their 
prognosis is poor, there is often an intense outpouring of emotions involving sadness, 
worry, grief, anger, blame and intermittent feelings of hope and fear.4, 5 The 
complexity of this process should not be underestimated, considering the various 
changes that may take place with regard to care patterns, role modifications, 
perspectives of loss and spiritual and psychosocial factors.6  
 
Grief, despair and high levels of anxiety and depression are prevalent among patients 
with advanced cancer and need to be considered during treatment. Evidence 
indicates that although mental disorders are common during palliative care, they are 
underdiagnosed.5, 7 Often unrecognised and inadequately treated, mental disorders 
cause significant distress for patients and caregivers.8 
 
Difficulty in accepting a poor prognosis is associated with greater rates of anxiety, 
depression and despair.9, 10 Lack of treatment for the psychological discomfort may be 
correlated with distress that is expressed as strongly as the distress that is induced by 
the underlying organic disease. In some cases, this distress may be associated with a 
greater chance of treatment failure.11 
 
Psychological disorders occur frequently and cause losses to the quality of life of 
cancer patients and family members. According to a report from the World Health 
Organization (WHO), approximately one-third of all individuals with cancer present 
some degree of anxiety and depression.12 The WHO recommends that healthcare 
professionals remain alert with regard to identifying such abnormalities and that they 
are trained to institute optimal treatment. In day-to-day palliative care, psychological 
distress is as upsetting as physical distress and, for many individuals, less tolerable 
than physical distress. Thus, palliative care aims to treat the patient’s physical 
symptoms and integrate this knowledge with the management of psychological 
aspects.13, 14 
 
The objective of this study was to evaluate the early indicators of anxiety and 
depression and their predictors among patients who were recently admitted to a 
palliative care facility. 
 
Methods. 
 
We conducted this cross-sectional study of 215 oncological patients over the age of 
18 years with a diagnosis of advanced cancer and without the possibility of a cure. 
The Ethics Committee of Barretos Cancer Hospital approved this study, and all of the 
patients signed the informed consent statement. These patients had been referred to 
the Palliative Care Outpatient Unit (PCOU) of Barretos Cancer Hospital (Barretos, 
São Paulo, Brazil) between April 2009 and December 2009. In the PCOU, the early 
identification of pain, anxiety and depression is a routine practice and is integrated 
with the admission process for all new patients.  
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A psychologist conducts the evaluation using a model for individual interviews 
targeted at assessing the patient’s level of adjustment in transitioning to palliative 
care; investigating his history of mental disorders; evaluating the degree of social 
support; and determining the current indicators for pain, anxiety and depression. 
 
The Barretos Cancer Hospital is composed of two units. Diagnosis, surgery, 
chemotherapy, radiotherapy and other invasive procedures are performed in Unit 
I.The Palliative Care and Pain Centre functions in Unit II. Patients who start to receive 
outpatient care in Unit II for the first time come either from this unit’s own ward after 
discharge or are sent from Unit I. When patients and their caregivers arrive, they go to 
the outpatient reception desk and are subsequently directed to a room where 
members of the nursing team receive them. At this point, the patients are screened 
for cancer symptoms and to identify which members of the multidisciplinary team are 
needed to optimally evaluate this patient.15 A psychological assessment is essential 
for all new patients at the outpatient clinic. After the initial assessments, the 
psychologist will define the appropriate type of follow-up for each patient: whether the 
patient should be admitted to the unit’s ward; whether he should enter the home 
attendance program; or whether he should return to the PCOU for a consultation.  
 
Measurements. 
 
To screen for psychological abnormalities, the Hospital Anxiety and Depression Scale 
(HADS) was applied. This instrument contains 14 questions in a 4-point Likert scale: 
seven anxiety indicators (HADS-A) and seven depression indicators (HADS-D). The 
depression and anxiety scores are the sum of questions HADS-D1 to HADS-D7 and 
questions HADS-A1 to HADS-A7, respectively. In accordance with the criteria 
suggested by Botega et al.16, patients with scores between 0 and 7 are classified as 
normal, scores between 8 and 10 are classified as mild cases of anxiety or 
depression, scores between 11 and 14 are classified as moderate cases of anxiety or 
depression and scores between 15 and 21 classified as severe cases of anxiety or 
depression.  
 
To evaluate anxiety and depression, HADS does not use the somatic criteria that are 
commonly used for chronic diseases, such as fatigue, loss of appetite and sleep 
abnormalities. HADS is an instrument for evaluating specific subjective symptoms and 
determining whether additional diagnostic methods are suggested for disease 
identification or patient treatment17. This scale can be used for early detection of 
psychological distress among cancer patients, who can be followed up with 
psychiatric interventions.18 To determine the anxiety and depression indicators, a cut-
off point of ≥ 8 was adopted. Having scores greater than or equal to the cut-off point 
of 11 for both anxiety and depression suggests a need for psychiatric assessment. 
 
We used a visual analogue scale (VAS) to measure pain.19 VAS, a self-assessment 
instrument, consists of a 10-cm ruler, without numbers, on which the only indications 
were “absence of pain” at the left end (corresponding to 0 cm) and “intolerable pain” 
at the right end (corresponding to 10 cm). The participants were instructed to make a 
mark on the straight line that corresponded to their own assessment of the intensity of 
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their pain. The higher the value was, the higher the intensity of the pain would be. 
Socio demographic data were retrieved from the patients’ medical files. 
   
Statistical Analysis. 
 
The chi-square test (or Fisher exact test) was used to assess the associations 
between the study variables. Correlation analyses were calculated using Spearman’s 
rank test. For the comparison between the HADS scores and the length of time from 
diagnosis until the first consultation within the palliative care service, the time (in 
months) was categorised into three groups delimited by the 25th and 75th percentiles, 
i.e., < 25th vs. between the 25th and 75th percentiles vs. > 75th percentile. We used 
the significance level of p < 0.05. For our statistical analyses, we used SPSS version 
18. 
 
Results. 
 
Clinical and socio demographic characteristics. 
 
There was a slight preponderance of women (53.5%) in the study sample. Among this 
sample, 128 patients (59.5%) were ≤ 60 years of age, and the mean age was 57 
years (standard deviation [SD] = 13). With regard to educational level, 25 patients 
(11.6%) were illiterate, 74 (34.4%) had not completed elementary education, 113 
(52.6%) had at least completed elementary education and three (1.4%) had an 
unspecified schooling level. 
 
The patients had been diagnosed between 1989 and 2009, and the median length of 
time (with interquartile range, 25th - 75th percentiles) between the cancer diagnosis 
and the first consultation in the Palliative Care Unit was 16 months (6-30 months). 
 
The primary tumour sites were as follows: head and neck (n = 37, 17.2%), urinary 
tract (n = 33, 15.3%), lower digestive system (n = 31, 14.4%), breast (n = 31, 14.4%), 
upper digestive system (n = 27, 12.6%), gynaecological tract (n = 22, 10.2%), 
unknown primary (n = 16, 7.4%), lung (n = 7, 3.3%), bone (n = 6, 2.8%) and 
neurological (n = 5, 2.3%).   
 
Pain, anxiety and depression indicators. 
 
The mean (SD) pain score was 0.89 (1.8). Among the participants, 70 (32.6%) 
presented some degree of pain, and 15 (7%) presented a pain level of ≥ 4 on the 
VAS.  
 
The mean (SD) HADS-A and HADS-D were 7 (4.1) and 7.3 (4.6), respectively. Using 
a cut-off point of ≥ 8, 80 patients (37.2%) had anxiety indicators, and 84 patients 
(39.1%) had depression indicators. We observed that 48 (22.4%) and 60 (27.9%) of 
the patients already had moderate or severe levels of anxiety and depression (HADS 
scores of ≥ 11), respectively, thus suggesting the need for psychiatric assessment. 
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A strong association was observed between the presence of anxiety and depression 
(p < 0.0001); 54 patients (64%) presented anxiety and depression indicators. 
Additionally, there was a highly significant correlation between anxiety and depression 
levels (r = 0.6, p < 0.0001). 
 
There were no significant associations between the presence of pain and anxiety (p = 
0.639), between the presence of pain and depression (p = 0.278) or between the 
length of treatment before palliative care and the presence of anxiety (p = 0.760) and 
depression (p = 0.427) (Table 1). Otherwise, a weakly significant correlation was 
observed between depression and pain (r = 0.15, p = 0.02) but not between anxiety 
and pain (r = 0.11, p = 0.09).  
 
There was a greater prevalence of HADS-A scores of ≥ 8 among breast cancer 
patients than among the remaining patients (18 of 31 patients, 58% vs. 70 of 184 
patients, 38%, respectively; p = 0.036). There were no differences in anxiety and 
depression rates regarding the other primary tumour sites (data not shown). 
 
Patients aged < 60 years reported higher levels of anxiety than patients older than 60 
years (58 of 121 patients, 48% vs. 30 of 94 patients, 32%, respectively; p = 0.018) 
(Table 1). There was no difference in depression rates regarding age. Women 
reported higher rates of anxiety than men (59 of 115 patients, 51% vs. 29 of 100 
patients, 29%, respectively; p = 0.001). The women also presented higher depression 
scores (66 of 115 patients, 57% vs. 34 of 100 male patients, 34%; p = 0.001) (Table 
1).  
 
Interestingly, patients with low educational levels reported lower rates of anxiety than 
did patients with higher educational levels (32 of 99 patients, 32% vs. 55 of 113 
patients, 49%, respectively; p = 0.016). Furthermore, patients with low educational 
levels also presented lower depression rates (38 of 99 patients, 38% vs. 59 of 113 
patients with higher educational levels, 52%; p = 0.04) (Table 1) 
  
Table 1. Anxiety and depression levels according to the Hospital Anxiety and 
Depression Scale and their associations with clinical variables 
 
Variable HADS-A 
n (%) 
p* HADS-D 
n (%) 
p* 
< 8 ≥ 8 < 8 ≥ 8 
Pain score (VAS)   0.639   0.278 
    0 to 3 119 
(59.5) 
81 (40.)  109 
(545) 
91 (45.5)  
    4 to 10 8 (53) 7 (47)  6 (40) 9 (60)  
Age (years)   0.018   0.453 
    < 60  63 (52) 58 (48)  62 (51) 59 (49)  
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    ≥ 60 64 (68) 30 (32)  53 (56) 41 (44)  
Gender   0.001   0.001 
    Male 71 (71) 29 (29)  66 (66) 34 (34)  
    Female 56 (49) 59 (51)  49 (43) 66 (57)  
Educational level   0.016   0.044 
    Lowera 67 (68) 32 (32)  61 (62) 38 (38)  
    Higherb 58 (51) 55 (49)  54 (48) 59 (52)  
Time since 
diagnosis 
(months) 
  0.760   0.427 
    ≤ 6  31 
(58.5) 
22 (41.5)  26 (49) 27 (51)  
    6 - 30 65 (61) 41 (39)  55 (52) 51 (48)  
    ≥ 30 31 (55) 25 (45)  34 (61) 22 (39)  
 
Legend: HADS-A: Hospital Anxiety and Depression Scale-anxiety, HADS-D: Hospital 
Anxiety and Depression Scale-depression; VAS: visual analogue scale. aIlliterate or 
incomplete elementary education; bat least completed elementary education; *chi-
square test. Significant results appear in bold. 
 
Discussion. 
 
In the present study, the patients who were recently admitted to the unit were profiled, 
so their immediate needs for psychosocial attention could be better understood. We 
perceived that the patients with psychological disorders did not necessarily present 
pain. These patients arrived at the PCOU already presenting anxiety and depression. 
This finding made us realise that there other factors besides the concept of palliative 
care are associated with these disorders. 
 
Mental disorders should be considered as an important source of distress for patients 
undergoing palliative care and their family members.11 Among cancer patients, 
anxiety and depression are frequent responses at the time of diagnosis and 
throughout the different treatment stages.20-23  
 
Several short instruments have been developed to screen for emotional distress.24 
The HADS is one of the recommended screening tools and is probably the most 
studied in the palliative care cancer setting.25, 26 The prevalence of anxiety and 
depression among cancer patients is discrepant between different studies, depending 
primarily on the gold standard criteria used.25, 27, 28 Our findings are similar to a 
previous study29 that used the HADS in palliative care, i.e., approximately 35% and 40 
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- 45% of patients had anxiety and depression, respectively. In the present study, all 
positive cases were referred for specific attention. 
 
Comparing the anxiety and depression findings from HADS, we observed that among 
the patients who presented depression, 64.3% also presented anxiety. This 
observation shows the importance of identifying the various signs and symptoms of 
anxiety and depression because they can occur concomitantly in many patients.23, 30, 
31  
 
Although the correlation analysis showed that there was a significant association 
between pain and the depression scores, this association was weak and probably not 
clinically important. In this sense, our findings do not corroborate the proposition that 
higher pain levels are associated with greater anxious responses and more intense 
depressed moods. According to several authors, psychological disorders such as 
mood disorders and anxiety, seem to occur predominantly among patients who suffer 
from chronic pain.32 
 
Chronic pain is directly related to depression, and anxiety is part of a complex 
reaction of fear and lack of knowledge of the diagnosis.33, 34 Chen et al.35 observed a 
greater prevalence of anxiety and, particularly, depression among patients who 
presented pain compared with cancer patients who were pain-free. However, the 
results from the present study partially contradict the reports in the literature. We 
found that 80 patients (37.2%) presented anxiety disorders and the 84 patients 
(39.1%) had depression, independent of any associated pain factor. Similarly, a 
Chinese study of 70 patients with advanced cancer and complaints of pain found that 
depression did not correlate with the severity of the pain.36  
 
Women represent a significant majority among cancer patients who present anxiety 
and depression.22, 36-38 The findings from the present study are in accordance with the 
literature regarding the association between female gender and diagnoses of both 
anxiety and depression. Moreover, younger patients are more prone to be identified 
with anxiety and depression,38, 39 perhaps because with increasing age, people 
acquire experience and resilience skills.40 Young patients experience greater difficulty 
in adjusting to and accepting the losses associated with cancer than do elderly 
patients.41 We observed that younger patients were more anxious than older patients, 
but there was no association between depression and age. 
 
The early referral of advanced cancer patients for palliative care is the most 
recommended approach today.42 There is strong evidence that advanced cancer 
patients present lower rates of anxiety and depression when treated by a palliative 
care team early during the course of their disease.43 However, early referral may also 
be indicative that these patients had not received any proposals for therapeutic 
treatment before their referral to the Palliative Care Unit and that they were at greater 
risk for developing anxiety disorders. Our data do not justify the hypothesis that the 
length of time from diagnosis until palliative care referral might be an important issue 
because no associations were identified regarding psychological disorders. 
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Several types of cancer may be associated with a high prevalence of depression, 
such as cancer of the oropharynx, pancreas, breast and lung.22 Among the 
populations studied, there were no significant associations between tumour site and 
depression. No primary tumour site was definitively associated with occurrences of 
depression. In contrast, breast cancer patients were more frequently anxious in our 
study. Considering the tendency among women to present anxiety, the association 
between anxiety and breast cancer is likely due to bias.  
 
In the present study, we observed that patients with low educational levels reported 
lower anxiety and depression rates. We hypothesise that those patients had 
inadequate knowledge about their disease and prognosis and that this lack of 
information could diminish their distress. Barretos Cancer Hospital is a public 
institution that primarily receives underserved patients from all Brazilian states. Most 
of the patients are poor and have a low educational level. To the best of our 
knowledge, this study is the first report that an association between higher levels of 
psychological symptoms and low educational level has not been shown.  
 
The present study has some limitations. The first limitation is that the low rates of pain 
found in our sample make it challenging to evaluate the interference of pain in 
psychological disorder scores. The second major limitation is the lack of outcome 
data. Because this was a cross-sectional study, we do not know how the depression 
and anxiety scores and their response to treatment (i.e., the outcome) evolved over 
time.  
 
Assessing depression among patients with advanced cancer may be difficult for both 
healthcare professionals and the patients’ caregivers. In addition to atypical 
symptomatic manifestations, depressed mood may be assessed as a normal reaction 
to the circumstances that patients undergoing palliative care experience.14, 44, 45 
 
In the present study, we found that cancer patients present a high prevalence of 
anxiety and depression during their first consultation in the PCOU. We are in 
agreement with others26 that the early identification of psychological disorders using 
HADS seems to be a feasible strategy for use in clinical practice. Additionally, our 
findings suggest that there is a need for rigorous psychological evaluation of women, 
younger patients and patients with higher educational levels because these patients 
show a greater propensity to anxiety and depression during the transition to palliative 
care compared with the other patients. 
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